PRN: Reaxys Announces Finalists of the 2011 Reaxys PhD Prize
PRN: Reaxys Announces Finalists of the 2011 Reaxys PhD Prize.
Reaxys Announces Finalists of the 2011 Reaxys PhD Prize
NEUCHATEL, Switzerland, May 26, 2011 /PRNewswire/ --
- The Reaxys(R) PhD Prize Awards Original and Innovative Research in Organic, Organometallic and Inorganic Chemistry
Reaxys today announced the 45 finalists for the 2011 Reaxys PhD Prize. This most prestigious international prize is open to all students studying for (or having completed in the last 12 months) a PhD in chemistry, and recognizes research and publication excellence in organic, inorganic, and organometallic chemistry. Launched in January, submissions consisted of a representative peer-reviewed piece of published research, a PhD Supervisor letter of recommendation and a CV. All entries were reviewed by a board of over 70 leading international chemists and judged for originality, innovation, importance to the field, applicability, rigor of approach and publication quality.
"We received nearly 300 submissions this year," said Dr. David Evans, Scientific Affairs Director at Elsevier Properties SA. "The finalists represent the highest quality research being performed today in some of the world's leading chemistry departments. The quality and importance of the work submitted for consideration clearly reflects the growing importance of this prize to the global chemistry community. Having personally read all of these contributions, I know that the Prize Review Committee will have an extremely tough choice in identifying this year's three overall winners from this group of 45 finalists," he continued.
All finalists are invited to attend the Reaxys PhD Prize Symposium and present a poster describing their research. The Symposium and Poster Session will be held at the 14 Asian Chemical Congress (http://www.14acc.org/), on Wednesday September 7, 2011, in Bangkok (http://www.14acc.org). A travel bursary will be provided to in part support attendance and registration fees for the conference.
The final selection of the winners of the 2011 Reaxys PhD Prize, announced in June, will be made by the Reaxys PhD Prize Committee who are all members of the Reaxys Advisory Board:
Prof. A. G. M. Barrett, Imperial College London,
Prof. B. M. Trost, Stanford University,
Prof. H. N. C. Wong, Chinese University of Hong Kong.
The three winners will be announced in early June. Each of the winners will receive a US$2000 check, and will be invited to give a paper at the 2011 Reaxys PhD Prize Symposium in Bangkok. A travel bursary will be provided to support attendance and registration fees for the conference.
This year's successful finalists are:
Jenefer Alam (Nanyang Technological University), Robert Andrews (University of North Carolina), Abdulkader Baroudi (Florida State University), Vikram Bhat (University of Chicago), Alan Burns (University of York), Matthew Cain (Dartmouth College), Justin Chalker (University of Oxford), Changle Chen (University of Chicago), Karl Collins (University of Manchester), Lei Fang (Northwestern University), Anastasia Hager (Ludwig-Maximilian University Munich), Xiaoyu Han (National University of Singapore), Shenshen Hu (Institute of Chemistry, Chinese Academy of Sciences), Masayuki Iwasaki (Kyoto University), Pankaj Jain (University of South Florida), Liqun Jin (Wuhan University), Ronen Kreizman (Weizmann Institute of Science)
Christian Andreas Kuttruff (Ludwig-Maximilian University Munich), Florian Lobermann (Ludwig-Maximilian University Munich), Andreas Lorbach (Goethe-University Frankfurt), Liang Qiu Lu (Central China Normal University), Ting Ma (National University of Singapore), Steven Malcolmson (Boston College), Michael Muratore (University of Oxford), Timothy Newhouse (Scripps Research Institute), Dixit Parmar (University of Manchester), Weidong Rao (Nanyang Technological University), Urs Rauwald (University of Cambridge), Alexander Reznichenko (Rutgers, the State University of New Jersey), Sarah Ryan (Monash University), Subhas Samanta (Indian Association for the Cultivation of Science), Corinna Schindler (ETH Zuerich), Christopher Serpell (University of Oxford), Xiao Shen (Shanghai Institute of Organic Chemistry) Zhuangzhi Shi (Peking University), Andrey Solovyev (University of Pittsburgh), Johannes Sprafke (University of Oxford), Haichao Xu (Washington University in St. Louis), Charles Yeung (University of Toronto), Elena Zaborova (University Pierre & Marie Curie), Jason Zbieg (University of Texas at Austin), Qi Zhang (Shanghai institute of organic chemistry), Haiyan Zhao (Texas A&M University), Jun Feng Zhao (Nanyang Technological University), Qianghui Zhou (Shanghai Institute of Organic Chemistry)
Reaxys is a workflow solution for research chemists. Offering a wealth of experimentally validated information, Reaxys combines reaction and substance data in organic, organometallic, inorganic and physical chemistry with synthesis planning. Researchers can get the information they need in a single overview, from source publications carefully selected for their importance and relevance to research chemists. Elsevier continues to engage with the chemistry community to ensure that Reaxys continues to reflect how chemists think and work. For more information please visit https://www.reaxys.com/info/
Reaxys(R) is a trademark owned and protected by Elsevier Properties SA and used under license.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell ( http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys (https://www.reaxys.com/info/), MD Consult (http://www.mdconsult.com/php/251359531-23/homepage) and Nursing Consult ( http://confidenceconnected.com/login/consult?env=PROD&URI=/nursing/index), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
About Elsevier Properties SA
Elsevier Properties SA is a center of excellence within the Reed Elsevier Group for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks including Reaxys(R), PharmaPendium(TM) and The Lancet (R) are owned and protected by Elsevier Properties SA and used under license.
Media Contact Tom Reller VP, Global Corporate Relations, Elsevier +1-215-239-3508 T.Reller@elsevier.com
Company Codes: LSE:REL, NYSE:ENL, NYSE:RUK, Euronext:REN